Clinical Trial Update: Bendamustine, Obinutuzumab, and Dexamethasone in Older Patients With Diffuse Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated bendamustine, obinutuzumab, and dexamethasone in older patients with diffuse large B-cell lymphoma. The study was terminated and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Decadron (Dexamethasone)
• Gazyva (Obinutuzumab)
• Treanda (Bendamustine)

Snippet

Sponsor: University of Chicago | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2018-03-14